Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts
NCT ID: NCT01353521
Last Updated: 2021-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2013-12-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contrast-enhanced ultrasound
Contrast-enhanced ultrasound
A contrast-enhanced ultrasound utilizes intravenous gas-filled microbubbles to enhance visualization in real time.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Contrast-enhanced ultrasound
A contrast-enhanced ultrasound utilizes intravenous gas-filled microbubbles to enhance visualization in real time.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* all patients undergoing CT evaluation of complex renal cysts at our centre (either initially or in follow-up)
* A complex renal cyst defined as Bosniak IIF, III or IV
Exclusion Criteria
* patients with contrast allergies
* patients with non-cystic, solid renal masses
* patients with simple cysts (Bosniak class I and II)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
St. Joseph's Healthcare Hamilton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anil Kapoor
MD, FRCSC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anil Kapoor, MD
Role: PRINCIPAL_INVESTIGATOR
McMaster Institute of Urology - St. Joseph's Healthcare Hamilton
Christopher Allard, MD
Role: STUDY_CHAIR
McMaster Institute of Urology - St. Joseph's Healthcare Hamilton
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEUSEVCRC
Identifier Type: -
Identifier Source: org_study_id